Most sinus infections don't require antibiotics
IDSA releases first rhinosinusitis guidelines, helps doctors distinguish between bacterial and viral cause
2012-03-22
(Press-News.org) EMBARGOED FOR MARCH 21, 2012, ARLINGTON, Va.] – The vast majority of sinus infections are caused by viruses and should not be treated with antibiotics, suggest new guidelines released by the Infectious Diseases Society of America (IDSA).
Nearly one in seven people are diagnosed with a sinus infection each year. Although sinus infections are the fifth leading reason for antibiotic prescriptions, 90 to 98 percent of cases are caused by viruses, which are not affected by antibiotics. Used inappropriately, antibiotics foster the development of drug-resistant superbugs.
"There is no simple test that will easily and quickly determine whether a sinus infection is viral or bacterial, so many physicians prescribe antibiotics 'just in case,'" said Anthony W. Chow, MD, chair of the guidelines panel and professor emeritus of infectious diseases at the University of British Columbia, Vancouver. "However, if the infection turns out to be viral – as most are – the antibiotics won't help and in fact can cause harm by increasing antibiotic resistance, exposing patients to drug side effects unnecessarily and adding cost."
The guidelines – the first developed by IDSA on this topic – provide specific characteristics of the illness to help doctors distinguish between viral and bacterial sinus infections. A sinus infection, called acute rhinosinusitis, is inflammation of the nasal and sinus passages that can cause uncomfortable pressure on either side of the nose and last for weeks. Most sinus infections develop during or after a cold or other upper respiratory infection, but other factors such as allergens and environmental irritants may play a role.
The guidelines recommend treating bacterial sinus infections with amoxicillin-clavulanate versus the current standard of care, amoxicillin. The addition of clavulanate helps to overcome antibiotic resistance by inhibiting an enzyme that breaks down the antibiotic. The guidelines also recommend against using other commonly used antibiotics, including azithromycin, clarithromycin and trimethoprim-sulfamethoxazole, due to increasing drug resistance.
The recommendation to use amoxicillin-clavulanate instead of amoxicillin is a major shift from older guidelines developed by other organizations. Dr. Chow notes that this recommendation was made due to increases in antibiotic resistance as well as the common use of pneumococcal vaccines, which have changed the pattern of bacteria that cause sinus infections.
The IDSA guidelines use the new GRADE system (Grading of Recommendations Assessment, Development and Evaluation), which is designed to more clearly assess the quality of evidence and strength of recommendations. The new IDSA guidelines note that randomized controlled trials referenced in previous guidelines often don't differentiate between bacterial and viral cause of infection, and therefore may not provide the best recommendations.
"These are the first evidence-based rhinosinusitis guidelines using the GRADE system," said Thomas M. File Jr., MD, co-author of the guidelines and chair of the Infectious Disease Section at Northeast Ohio Medical University, Rootstown, Ohio. "Health care providers face difficulties when treating sinus infections, and these guidelines provide the best recommendations available. The guidelines are transparent, clearly stating the level of evidence for each recommendation and pointing out where we need more research."
The IDSA rhinosinusitis guidelines contain a number of other recommendations, including:
How to tell the difference – The guidelines note a sinus infection is likely caused by bacteria and should be treated promptly with antibiotics if:
symptoms last for 10 days or more and are not improving (previous guidelines suggested waiting seven days); or
symptoms are severe, including fever of 102 or higher, nasal discharge and facial pain lasting 3-4 days in a row; or
symptoms get worse, with new fever, headache or increased nasal discharge, typically after a viral upper respiratory infection that lasted five or six days and initially seemed to improve.
Shorter treatment time – Most guidelines to date have recommended 10 days to two weeks of antibiotic treatment for a bacterial infection. However, the IDSA guidelines suggest five to seven days of antibiotics is long enough to treat a bacterial infection without encouraging resistance. The IDSA guidelines still do recommend children receive antibiotic treatment for 10 days to two weeks.
Avoid decongestants and antihistamines – Whether the sinus infection is bacterial or viral, decongestant and antihistamines are not helpful and may make symptoms worse. Nasal steroids can help ease symptoms in people who have sinus infections and a history of allergies.
Saline irrigation may help – The guidelines note nasal irrigation using a sterile solution – including sprays, drops or liquid – may help relieve some symptoms. However, the guidelines note this may not be helpful in children because they are less likely to tolerate the discomfort of the therapy.
To ease symptoms of a sinus infection, Dr. File said he recommends patients take acetaminophen for sinus pain, use saline irrigation and drink plenty of fluids.
The voluntary guidelines are not intended to take the place of a doctor's judgment, but rather support the decision-making process, which must be individualized according to each patient's circumstances.
###The 11-member guidelines panel comprises rhinosinusitis experts representing a variety of organizations, including the Centers for Disease Control and Prevention (CDC), the American College of Physicians, and the Society of Academic Medicine. In addition to Drs. Chow and File, the rhinosinusitis guidelines panel includes: Michael S. Benninger, Itzhak Brook, Jan L. Brozek, Ellie J.C. Goldstein, Lauri A. Hicks, George A. Pankey, Mitchel Seleznick, Gregory Volturo, and Ellen R. Wald.
IDSA has published more than 50 treatment guidelines on various conditions and infections, ranging from HIV/AIDS to Clostridium difficile. As with other IDSA guidelines, the rhinosinusitis guidelines will be available in a format designed for iPhones and other mobile devices, and in a pocket-sized quick-reference edition.
Note: For a copy of the rhinosinusitis guidelines, to be published in the April 15 issue of Clinical Infectious Diseases, please contact Ashley Mattys at (312) 558-1770 or amattys@pcipr.com. The guidelines are embargoed until 12:01 a.m. EDT on March 21, 2012.
Founded in 1979, Clinical Infectious Diseases publishes clinical articles twice monthly in a variety of areas of infectious disease, and is one of the most highly regarded journals in this specialty.
The Infectious Diseases Society of America (IDSA) is an organization of physicians, scientists, and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, patient care, prevention, and public health. The Society, which has nearly 10,000 members, was founded in 1963 and is based in Arlington, Va. For more information, see www.idsociety.org.
ELSE PRESS RELEASES FROM THIS DATE:
Perimeter Hotel Near Atlanta Announces the Economic Stimulus Package
2012-03-22
The Holiday Inn Express & Suites Atlanta N- Perimeter Mall Hotel, at Atlanta Perimeter Center, announces the Economic Stimulus Package. Available for a limited time, guests who book this package will be rewarded with a $25 gift card, per paid night, to one of America's favorite retailers like Best Buy, Target, Wal-Mart, Home Depot, and Amazon.com. Available while supplies last; some restrictions may apply. Rates start at $124.00 USD per night.
A top choice among other hotels in Atlanta Perimeter, travelers are sure to enjoy their stay at the Holiday Inn Express ...
Team finds atomic structure of molecule that binds to opioids in the brain
2012-03-22
LA JOLLA, CA -- March 21, 2012 -- Scientists have for the first time determined the three-dimensional atomic structure of a human opioid receptor, a molecule on the surface of brain cells that binds to opioids and is centrally involved in pleasure, pain, addiction, depression, psychosis, and related conditions. Dozens of legal and illegal drugs, from heroin to hospital anesthetics, work by targeting these receptors. The detailed atomic structure information paves the way for the design of safer and more effective opioid drugs.
"This finding is going to have a major impact ...
Atlanta Airport Hotel Near GA Dome Offers Nearby Lodging to the 2012 NCAA South Regional Men's Basketball Tournament
2012-03-22
The Hilton Garden Inn Atlanta Airport Hotel (North) offers convenient lodging to travelers attending the 2012 NCAA South Regional Men's Basketball Tournament. The Road to the Final Four , the NCAA South Regional (Division I) tournament will be held from March 23 - 25, 2012 at the Georgia Dome in downtown Atlanta, GA. Featuring the NCAA "Sweet 16 " and "Elite Eight " Rounds of the NCAA Tournament, this year's winner of the two-day event will be awarded a spot in the 2012 NCAA Final FOUR that will be held in New Orleans.
"Conveniently located only ...
Cancer cells in blood predict chances of survival and can help target breast cancer treatment
2012-03-22
Vienna, Austria: Detecting the presence of circulating tumour cells (CTCs) in the blood of women with early breast cancer after surgery but before the start of chemotherapy can provide useful information about their chances of surviving the disease. CTCs are cancer cells which are detectable in patients with a solid tumour and their value in the prognosis of metastatic breast cancer has been known for a few years. Until now, however, there has been little information about their role in early disease.
Results to be presented today (Thursday) from the first large-scale ...
Door2Tour.com Reports the Return of the Staycation
2012-03-22
Door2Tour.com has revealed that the 'staycation' could be making a comeback. The latest figures from the tour operator have shown that sales of UK breaks have increased by approximately 9% compared to the same period last year. This has been put down to the UK being under the spotlight during 2012.
There are a variety of factors causing this resurgence in UK breaks with the main one being the UK playing host to some top events during 2012 such as the Queens Diamond Jubilee, The Olympics, the 100th anniversary of the maiden voyage of RMS Titanic and the 200th anniversary ...
Dense breasts can nearly double the risk of breast cancer recurrence
2012-03-22
Vienna, Austria: Women aged 50 and over with breasts that have a high percentage of dense tissue are at greater risk of their breast cancer recurring, according to Swedish research presented at the eighth European Breast Cancer Conference (EBCC-8) in Vienna today (Wednesday).
Dr Louise Eriksson and her colleagues from the Karolinska Institutet (Stockholm, Sweden) found that women with denser breasts had nearly double the risk of their cancer recurring, either in the same breast or in the surrounding lymph nodes, than women with less dense breasts. They warn that doctors ...
20-year results from breast cancer screening program show a significant drop in deaths, limited harm and reasonable costs
2012-03-22
Vienna, Austria: Results from one of the longest-running national breast cancer screening programmes have shown that it has contributed to a drop in deaths from the disease, that any harm caused by the screening, such as false positives and over-diagnosis, has been limited, and that the costs have been reasonable.
The Dutch population-based mammography breast cancer screening programme began in 1989, and today (Wednesday) Mr Jacques Fracheboud, a senior researcher at the Erasmus University Medical Center (Rotterdam, The Netherlands), reported on the first 20 years to ...
MRI screening for women with a family history of breast cancer but no genetic predisposition
2012-03-22
Vienna, Austria: Adding magnetic resonance imaging (MRI) to standard breast cancer screening approaches is expensive, though it could be cost effective for a group of women who may not have inherited the breast cancer susceptibility genes, but who have a familial risk of developing the disease. This is the conclusion of research presented at the eighth European Breast Cancer Conference (EBCC-8) today (Wednesday).
Women who carry the BRCA1/2 gene mutations are known to be at much higher risk of developing breast cancer, and at an early age; for this reason most breast ...
Hairtrade Introduce No Inhibitions to Hair Styling Range
2012-03-22
Hairtrade, the UK's leading retailer of hair extensions, hair care and beauty products has added an exciting new line to its hair styling range.
No Inhibition is a sophisticated hair styling line which consists of a number of products, from smoothing creams, styling gels and shaping pomades to moulding muds, modelling wax and texturizing foams. The elegance of this line is evident in the unique and stylish shaped bottles and colourful chic packaging.
Keven Kou, managing director of I&K International Limited said: "We've been looking for some new and exciting ...
Breast cancer screening and better treatment both help to save significant numbers of lives
2012-03-22
Vienna, Austria: A Dutch study of the effectiveness of breast cancer screening shows that, even with improved treatments for the disease, population-based mammography programmes still save a significant number of lives.
The finding, presented today (Wednesday) at the eighth European Breast Cancer Conference (EBCC-8) in Vienna, will add further fuel to the debate about whether or not breast cancer screening does more harm than good. Those who argue against national screening programmes say that treatment for the disease is so effective nowadays that the chances of surviving ...
LAST 30 PRESS RELEASES:
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project
[Press-News.org] Most sinus infections don't require antibioticsIDSA releases first rhinosinusitis guidelines, helps doctors distinguish between bacterial and viral cause